The Forbidden Discussion on mRNA IgG4

May 25, 2024 | COVID-19, Research, Treatment

Responsive Centered YouTube Video
Discussion on suppressed information regarding IgG4 and COVID-19 implications.

  • Dr. McMillan emphasizes the importance of understanding autoimmunity in the context of the pandemic. • 0:03

  • A presentation on the potential consequences of falling vax antibodies was blocked from discussion. • 1:28

  • The concept of IgG4 and its implications are being suppressed by the scientific community. • 2:40

Concerns raised about potential implications of increased IgG4 levels post mRNA vaccination.

  • Increased IgG4 levels after mRNA vaccination may have significant implications. • 2:56

  • IgG4 levels can increase almost 4,000 times post mRNA vaccination. • 3:29

  • Vaccination with mRNA leads to a significant increase in IGG percentage. • 3:38

  • Severe COVID-19 is characterized by issues in the bloodstream, not just the lungs. • 5:13

  • Concerns about spike protein causing damage similar to the virus due to ACE2 binding. • 5:39

Discussion on potential autoimmune response triggered by circulating Spike protein and free A2 binding in severe covid-19 cases.

  • Circulating Spike protein binding to A2 may trigger autoimmune response in severe covid-19 cases. • 5:48

  • Elevated serum A2 levels linked to severe covid-19, especially in older individuals with comorbidities. • 6:39

  • Free floating A2 can potentially bind to Spike protein, leading to immune system targeting both. • 7:28

  • Autoantibodies to A2 observed in patients with severe covid-19, indicating autoimmune response. • 7:43

  • Theoretical possibility of free floating Spike protein binding to A2 and becoming a target for the immune system. • 8:08

  • IgG4 antibodies may play a role in dampening immune response to antigens, similar to bee venom tolerance. • 8:26

Discussion on implications of declining IgG4 levels in relation to severe COVID-19 and vaccination.

  • Elevated IgG4 levels may protect against cytokine storms and autoimmune responses. • 8:54

  • Decline in IgG4 levels could lead to severe COVID-19 post-vaccination. • 9:32

  • Challenges in managing individuals with elevated IgG4 levels and potential risks. • 10:12

  • Nuanced approach needed for addressing severe COVID-19 in boosted individuals. • 10:22

  • Lack of clarity on identifying individuals who may benefit from interventions. • 10:46

  • Political and scientific challenges in discussing and addressing these issues openly. • 11:04

  • Scientific community faces obstacles in raising difficult questions and addressing problems. • 11:13

Implications of waning IgG4 protection and the need for alternative solutions in the pandemic.

  • Waning IgG4 may lead to more severe disease in boosted individuals. • 11:55

  • Lack of alternative options for boosting immunity is concerning. • 12:03

  • Acknowledgment of the issue and finding solutions are crucial. • 12:27

  • Importance of remaining nuanced, objective, and scientific in approach. • 13:03